In this episode of the podcast, Joe Moore interviews co-founder and CEO of Journey Clinical, Jonathan Sabbagh. Journey Clinical is a telehealth platform specializing in remote and in-person ketamine-assisted psychotherapy, but what makes them a bit unique is their larger focus on the needs of the psychotherapist; helping approved psychotherapists integrate KAP into their practices, and by building out a platform to facilitate the delivery of customized treatments of all modalities to their patients under the same umbrella. Sabbagh tells his story of 20 years in finance leading to burnout, ayahuasca, and a career change, and discusses data privacy; why ketamine is just an adjunct; how Journey’s process works; the importance of building a safe container (in therapy and digitally); wearables and the future of combined tools; what he’s most excited about; what it meant to see his company’s banner hanging at Horizons; and why it’s important to have a growing industry be led by true believers.

The post PT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care appeared first on Psychedelics Today.

Previous articleMydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients
Next articleNuminus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product